A
Aralex
Aachen research explorer
Sign in
Menu
Papers
Authors
Topics
Journals
Patents
Institutions
Departments
Sign in
Papers
Authors
Topics
Journals
Patents
Organizations
Institutions
Departments
Company
ROR
OpenAlex
Janssen (Netherlands)
▲
Sign in to save
550 stored papers ·
Search its papers →
·
Its authors →
Papers
550
Search
Sort
Most cited
Newest
Oldest
Patent citations
Title
Any type
article
review
book-chapter
conference-paper
preprint
dissertation
book
dataset
other
Any field
Agricultural and Biological Sciences
Arts and Humanities
Biochemistry, Genetics and Molecular Biology
Business, Management and Accounting
Chemical Engineering
Chemistry
Computer Science
Decision Sciences
Dentistry
Earth and Planetary Sciences
Economics, Econometrics and Finance
Energy
Engineering
Environmental Science
Health Professions
Immunology and Microbiology
Materials Science
Mathematics
Medicine
Neuroscience
Nursing
Pharmacology, Toxicology and Pharmaceutics
Physics and Astronomy
Psychology
Social Sciences
Veterinary
Open access
Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study
2021
The Journal of Infectious Diseases
article
Medicine
Respiratory viral infections research
Open access
88
citations
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment
2020
Vaccine
article
Biochemistry, Genetics and Molecular Biology
Virus-based gene therapy research
Open access
cited by 2 patents
84
citations
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
2022
The Lancet Infectious Diseases
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
84
citations
Structure-Based Design of Prefusion-Stabilized Filovirus Glycoprotein Trimers
2020
Cell Reports
article
Medicine
Viral Infections and Outbreaks Research
Open access
cited by 15 patents
80
citations
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine
2021
Annals of Internal Medicine
article
Medicine
Mosquito-borne diseases and control
80
citations
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
2020
npj Vaccines
article
Medicine
Viral Infections and Outbreaks Research
Open access
76
citations
A Large‐Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands
2020
Movement Disorders
article
Medicine
Lysosomal Storage Disorders Research
Open access
cited by 2 patents
75
citations
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
2020
Nature Medicine
article
Immunology and Microbiology
HIV Research and Treatment
Open access
cited by 5 patents
74
citations
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
2023
JAMA
article
Medicine
COVID-19 Clinical Research Studies
Open access
71
citations
Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP
2021
The Journal of Experimental Medicine
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
cited by 6 patents
71
citations
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa
2021
PLoS Medicine
article
Medicine
Viral Infections and Outbreaks Research
Open access
cited by 1 patent
69
citations
EIF2AK2 Missense Variants Associated with Early Onset Generalized Dystonia
2020
Annals of Neurology
article
Medicine
Neurological disorders and treatments
Open access
68
citations
Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques
2021
Cell
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
66
citations
Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.
2023
Journal of Clinical Oncology
conference-abstract
Medicine
Multiple Myeloma Research and Treatments
Open access
66
citations
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial
2022
PLoS Medicine
article
Medicine
Viral Infections and Outbreaks Research
Open access
65
citations
Antibody effector functions are associated with protection from respiratory syncytial virus
2022
Cell
article
Medicine
Respiratory viral infections research
Open access
cited by 6 patents
62
citations
Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions
2022
Proceedings of the National Academy of Sciences
article
Medicine
Influenza Virus Research Studies
Open access
cited by 9 patents
61
citations
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
2021
npj Vaccines
article
Chemistry
Carbohydrate Chemistry and Synthesis
Open access
cited by 1 patent
60
citations
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
2022
JAMA Network Open
article
Medicine
SARS-CoV-2 and COVID-19 Research
Open access
57
citations
An introduction to the Marburg virus vaccine consortium, MARVAC
2022
PLoS Pathogens
article
Medicine
Viral Infections and Outbreaks Research
Open access
54
citations
41–60 of 550
← Previous
Page 3 / 28
Next →
Most cited authors
Search all →
▲
Dan H. Barouch
Beth Israel Deaconess Medical Center
·
Harvard University
Medicine
64.1k
citations
122
h-index
1
Aachen papers
▲
Marc J. M. Bonten
Biochemistry, Genetics and Molecular Biology
63.2k
citations
122
h-index
1
Aachen papers
▲
M. Juliana McElrath
University of Cape Town
·
University of Washington
Immunology and Microbiology
55.8k
citations
91
h-index
1
Aachen papers
▲
Pierre Van Damme
University of Antwerp
Social Sciences
34.9k
citations
87
h-index
1
Aachen papers
▲
Hanneke Schuitemaker
Johnson & Johnson (Netherlands)
Immunology and Microbiology
31.1k
citations
88
h-index
85
Aachen papers
▲
Ian Smith
Queensland Health
Biochemistry, Genetics and Molecular Biology
30.1k
citations
63
h-index
1
Aachen papers
▲
JERALD C. SADOFF
Johnson & Johnson (Netherlands)
Immunology and Microbiology
25.2k
citations
76
h-index
52
Aachen papers
▲
Peter W. M. Hermans
Utrecht University
·
University Medical Center Utrecht
Medicine
19.3k
citations
69
h-index
4
Aachen papers
▲
Stephen C. De Rosa
University of Washington
·
Fred Hutch Cancer Center
Immunology and Microbiology
15.9k
citations
53
h-index
1
Aachen papers
▲
JAN T. POOLMAN
Johnson & Johnson (Netherlands)
Immunology and Microbiology
15.3k
citations
67
h-index
33
Aachen papers
▲
Frank Struyf
Janssen (Belgium)
·
GlaxoSmithKline (United Kingdom)
Medicine
14.1k
citations
44
h-index
1
Aachen papers
▲
Wim V. Damme
Vrije Universiteit Brussel
·
Instituut voor Tropische Geneeskunde
Economics, Econometrics and Finance
13.3k
citations
59
h-index
1
Aachen papers
▲
JESSICA T. VERMEULEN
Johnson & Johnson (Netherlands)
Medicine
10.5k
citations
42
h-index
51
Aachen papers
▲
Kevin Song
BC Cancer Agency
·
University of British Columbia
Medicine
10.3k
citations
42
h-index
1
Aachen papers
▲
Gert C. Scheper
Johnson & Johnson (Netherlands)
Neuroscience
9.87k
citations
45
h-index
18
Aachen papers
▲
Mathai Mammen
Biochemistry, Genetics and Molecular Biology
9.19k
citations
26
h-index
2
Aachen papers
▲
Bart Spiessens
Biochemistry, Genetics and Molecular Biology
8.95k
citations
24
h-index
1
Aachen papers
▲
Veronica V. Rezelj
Johnson & Johnson (United States)
·
Janssen (Netherlands)
Medicine
8.78k
citations
21
h-index
5
Aachen papers
▲
Macaya Douoguih
Johnson & Johnson (Netherlands)
Medicine
8.4k
citations
35
h-index
63
Aachen papers
▲
Kathryn E. Stephenson
Beth Israel Deaconess Medical Center
·
Harvard University
Medicine
8.09k
citations
39
h-index
1
Aachen papers